Iron Triangle Partners LP
Sector Allocation
- Healthcare96.5%$844.3M
- Technology3.5%$30.4M
AUM History
13fpro.ai/research/fund/iron-triangle-partners-lp-1779763
Conviction and streaks
Diversifying · top 10 = 53.2%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q4 2025
CRL
$75.7MISRG
$53.5MRGEN
$52.5MJAZZ
$49.7MVCYT
$41.3MBSX
$40.1MWAT
$39.9MBKD
$37.7MLLY
$37.7MBRKR
$37.4MVRTX
$34.9MCVS
$34.3MFTRE
$34.3MMMSI
$34.0MBTSG
$33.6MDOCS
$30.4MTECH
$27.5MATEC
$27.1MAHCO
$26.0MNVST
$25.8M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/iron-triangle-partners-lp-1779763
Iron Triangle Partners LP 13F holdings — Q4 2025
$874.7M portfolio (+24.4% QoQ) · 27 holdings · Q4 2025 13F · top 10 are 53% of the stock portfolio
$75.7M
8.7% of stocks
+42%This quarter—Since Q-end—HeldAIQuality49.3#1,696Est. buy—$53.5M
6.1% of stocks
NewThis quarter—Since Q-endNew this quarterHeldAIQuality76.2#54Est. buy—$52.5M
6.0% of stocks
+19%This quarter—Since Q-end—HeldAIQuality52.0#1,516Est. buy—$49.7M
5.7% of stocks
+95%This quarter—Since Q-end—HeldAIQuality—Est. buy—$41.3M
4.7% of stocks
+102%This quarter—Since Q-end—HeldAIQuality67.3#346Est. buy—$40.1M
4.6% of stocks
NewThis quarter—Since Q-endNew this quarterHeld$39.9M
4.6% of stocks
NewThis quarter—Since Q-endNew this quarterHeld$37.7M
4.3% of stocks
+23%This quarter—Since Q-end—Held$37.7M
4.3% of stocks
-29%This quarter—Since Q-end—Held$37.4M
4.3% of stocks
NewThis quarter—Since Q-endNew this quarterHeld
| # | Company | Value | Weight | This quarter | Since Q-end | Held | AI quality | Est. buy | |
|---|---|---|---|---|---|---|---|---|---|
| 1 | $75.7M | 8.7% | +42% | — | — | 49.3#1,696 | — | ||
| 2 | $53.5M | 6.1% | New | — | New this quarter | 76.2#54 | — | ||
| 3 | $52.5M | 6.0% | +19% | — | — | 52.0#1,516 | — | ||
| 4 | $49.7M | 5.7% | +95% | — | — | — | — | ||
| 5 | $41.3M | 4.7% | +102% | — | — | 67.3#346 | — | ||
| 6 | $40.1M | 4.6% | New | — | New this quarter | AI quality score is Pro: unlock with a free trial | — | ||
| 7 | $39.9M | 4.6% | New | — | New this quarter | AI quality score is Pro: unlock with a free trial | — | ||
| 8 | $37.7M | 4.3% | +23% | — | — | AI quality score is Pro: unlock with a free trial | — | ||
| 9 | $37.7M | 4.3% | -29% | — | — | AI quality score is Pro: unlock with a free trial | — | ||
| 10 | $37.4M | 4.3% | New | — | New this quarter | AI quality score is Pro: unlock with a free trial | — |
All holdings — Iron Triangle Partners LP (Q4 2025)
27 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | VERTEX PHARMACEUTICALS INC / MA | Healthcare | $34.9M | 4.0% | 77K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | CVS HEALTH Corp | Healthcare | $34.3M | 3.9% | 432K | -46% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | Fortrea Holdings Inc. | Healthcare | $34.3M | 3.9% | 1.99M | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | MERIT MEDICAL SYSTEMS INC | Healthcare | $34.0M | 3.9% | 386K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | BrightSpring Health Services, Inc. | Healthcare | $33.6M | 3.8% | 897K | -28% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | Doximity, Inc. | Technology | $30.4M | 3.5% | 687K | +227% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | BIO-TECHNE Corp | Healthcare | $27.5M | 3.1% | 467K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | Alphatec Holdings, Inc. | Healthcare | $27.1M | 3.1% | 1.29M | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | AdaptHealth Corp. | Healthcare | $26.0M | 3.0% | 2.61M | +36% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Envista Holdings Corp | Healthcare | $25.8M | 3.0% | 1.19M | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | UNITEDHEALTH GROUP INC | Healthcare | $23.1M | 2.6% | 70K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | ABBOTT LABORATORIES | Healthcare | $22.0M | 2.5% | 175K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | IDEAYA Biosciences, Inc. | Healthcare | $16.2M | 1.9% | 467K | +73% | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | Biohaven Ltd. | Healthcare | $10.8M | 1.2% | 958K | New | — | — | 13F | |
| 25 | Xenon Pharmaceuticals Inc. | Healthcare | $10.5M | 1.2% | 234K | New | — | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $DNTH | Dianthus Therapeutics, Inc. /DE/ | Healthcare | $9.5M | 1.1% | 231K | New | |||
| 27 | $MLYS | Mineralys Therapeutics, Inc. | Healthcare | $9.3M | 1.1% | 257K | New |
What changed in Q4 2025
Against the previous quarter's 13F: 16 new, 8 added to, 3 trimmed, 14 sold out. Share-count changes; largest moves by dollar size first.
New positions (16)
$ISRGINTUITIVE SURGICAL INC$53.5M
first bought this quarter
$BSXBOSTON SCIENTIFIC CORP$40.1M
first bought this quarter
$WATWATERS CORP /DE/$39.9M
first bought this quarter
$BRKRBRUKER CORP$37.4M
first bought this quarter
$VRTXVERTEX PHARMACEUTICALS INC / MA$34.9M
first bought this quarter
$FTREFortrea Holdings Inc.$34.3M
first bought this quarter
+10 more in the Excel export
Added to (8)
$JAZZJazz Pharmaceuticals plc+95%
now $49.7M
$CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.+42%
now $75.7M
$DOCSDoximity, Inc.+227%
now $30.4M
$VCYTVERACYTE, INC.+102%
now $41.3M
$RGENREPLIGEN CORP+19%
now $52.5M
$BKDBrookdale Senior Living Inc.+23%
now $37.7M
+2 more in the Excel export
Trimmed (3)
Holdings by quarter
Every 13F Iron Triangle Partners LP has filed, 24 earlier quarters. Pick one to see what it held then.
Portfolio Overview
Iron Triangle Partners LP disclosed 27 positions worth $874.7M in its Form 13F-HR for Q4 2025, led by $CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.) at 8.7% of the equity portfolio, followed by $ISRG and $RGEN. During the quarter the fund opened 16 new positions and exited 14 — including a new stake in $ISRG and a full exit from $DXCM. The portfolio is most concentrated in Healthcare (96.5% of disclosed assets). All figures are sourced directly from Iron Triangle Partners LP’s Form 13F-HR filing with the SEC under CIK 1779763.
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Iron Triangle Partners LP
13F Pro is an AI hedge fund tracker and stock research platform. For Iron Triangle Partners LP (SEC CIK: 1779763), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Iron Triangle Partners LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.